InvestorsHub Logo
Post# of 252971
Next 10
Followers 837
Posts 120332
Boards Moderated 18
Alias Born 09/05/2002

Re: genisi post# 106761

Wednesday, 10/20/2010 2:59:52 PM

Wednesday, October 20, 2010 2:59:52 PM

Post# of 252971
The phase-3b switching study mentioned in #msg-55725398 implies that GILD is thinking about Btripla in the second-line setting following Truvada + a PI in the first line. This is a shrinking market, however, as Intelence and Isentress have been pecking away at the market share of the PI’s in the first line.

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.